Evidence map›Paper›PMID 32588496›Full record

ArticleMolecular genetics & genomic medicine2020

FARP-1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family.

Francesca Cucinotta, Arianna Ricciardello, Laura Turriziani, Giorgia Calabrese, Marilena Briguglio, Maria Boncoddo, Fabiana Bellomo, Pasquale Tomaiuolo, Silvia Martines, Marianna Bruschetta and 12 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Francesca CucinottaInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.ORCID 0000-0001-8477-7826
Arianna RicciardelloInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Laura TurrizianiInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Giorgia CalabreseInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Marilena BriguglioInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Maria BoncoddoInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Fabiana BellomoInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Pasquale TomaiuoloInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Silvia MartinesInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Marianna BruschettaInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Francesca La Fauci BelponerInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Tiziana Di BellaInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
Costanza ColombiDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Marco BaccarinMafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy.
Chiara PicinelliMafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy.
Paola CastronovoMafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy.
Carla LintasService for Neurodevelopmental Disorders & Laboratory of Molecular Psychiatry and Neurogenetics, University "Campus Bio-Medico", Rome, Italy.ORCID 0000-0003-1209-8554
Roberto SaccoService for Neurodevelopmental Disorders & Laboratory of Molecular Psychiatry and Neurogenetics, University "Campus Bio-Medico", Rome, Italy.
Thomas BiedererDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Barbara KellamGenetics & Genome Biology Program, Toronto, Canada.
Stephen W SchererGenetics & Genome Biology Program, Toronto, Canada.
Antonio M PersicoInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.ORCID 0000-0001-8910-4479
University of Messina · ITUniversità Campus Bio-Medico · ITHospital for Sick Children · CAUniversity of Michigan · USUniversity of Toronto · CAYale University · US

Funding

Mechanisms of SynCAM-Induced Synapse FormationR01DA018928 · NIDA · YALE UNIVERSITY · PI BIEDERER, THOMAS · 2005 to 2021
$4.6M
NIDA NIH HHS R01 DA018928
6 · The paper itself

Abstract

backgroundChildren with autism spectrum disorder (ASD) display impressive clinical heterogeneity, also involving treatment response. Genetic variants can contribute to explain this large interindividual phenotypic variability.

methodsArray-CGH (a-CGH) and whole genome sequencing (WGS) were performed on a multiplex family with two small children diagnosed with ASD at 17 and 18 months of age. Both brothers received the same naturalistic intervention for one year according to the Early Start Denver Model (ESDM), applied by the same therapists, yielding dramatically different treatment outcomes.

resultsThe older sibling came out of the autism spectrum, while the younger sibling displayed very little, in any, improvement. This boy was subsequently treated applying a structured Early Intensive Behavioral Intervention paired with Augmentative Alternative Communication, which yielded a partial response within another year. The ESDM nonresponsive child carries a novel maternally inherited 65 Kb deletion at chr. 13q32.2 spanning FARP1. Farp1 is a synaptic scaffolding protein, which plays a significant role in neural plasticity.

conclusionThese results represent a paradigmatic example of the heuristic potential of genetic markers in predicting treatment response and possibly in supporting the targeted prescription of specific early intervention approaches.

Indexed as

Behavior TherapyAutism Spectrum DisorderChild, PreschoolChromosomes, Human, Pair 13Early Medical InterventionGene DeletionHumansMaleMutationPedigreeRho Guanine Nucleotide Exchange FactorsTreatment OutcomeFARP1 protein, humanRho Guanine Nucleotide Exchange Factorsautism spectrum disorderbiomarkersFARP1neuronal plasticitytreatment outcome

Identifiers

PMID32588496
PMCPMC7507005
OpenAlexW3038034689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.